Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia
Hepatitis Research and Treatment · 2011
DOI: 10.1155/2011/582945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2011. Verfasst von Maria-Cristina Navas und 23 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Gastrohepatologia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIEHS NIH HHS.
Abstract (Originalsprache)
Hepatocellular Carcinoma (HCC) is a leading cause of cancer-related death worldwide. Globally, the most important HCC risk factors are Hepatitis B Virus (HBV) and/or Hepatitis C Virus (HCV), chronic alcoholism, and dietary exposure to aflatoxins. We have described the epidemiological pattern of 202 HCC samples obtained from Colombian patients. Additionally we investigated HBV/HCV infections and TP53 mutations in 49 of these HCC cases. HBV biomarkers were detected in 58.1% of the cases; HBV genotypes F and D were characterized in three of the samples. The HCV biomarker was detected in 37% of the samples while HBV/HCV coinfection was found in 19.2%. Among TP53 mutations, 10.5% occur at the common aflatoxin mutation hotspot, codon 249. No data regarding chronic alcoholism was available from the cases. In conclusion, in this first study of HCC and biomarkers in a Colombian population, the main HCC risk factor was HBV infection.
Autor:innen und Institutionen
- Grupo de Gastrohepatologia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Förderung
- NIEHS NIH HHS
Zitieren
APA
Navas, M. C., Suarez, I., Carreño, A., Uribe, D., Rios, W. A., Cortes-Mancera, F., Martel, G., Vieco, B., Lozano, D., Jimenez, C., Gouas, D., Osorio, G., Hoyos, S., Restrepo, J. C., Correa, G., Jaramillo, S., Lopez, R., Bravo, L. E., Arbelaez, M. P., …, & Hainaut, P. (2011). Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia. Hepatitis Research and Treatment. https://doi.org/10.1155/2011/582945
Vancouver
Navas MC, Suarez I, Carreño A, Uribe D, Rios WA, Cortes-Mancera F, et al. Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia. Hepatitis Research and Treatment. 2011. doi:10.1155/2011/582945
BibTeX
@article{Navas2011,
author = {Navas, Maria-Cristina and Suarez, Iris and Carreño, Andrea and Uribe, Diego and Rios, Wilson Alfredo and Cortes-Mancera, Fabian and Martel, Ghyslaine and Vieco, Beatriz and Lozano, Diana and Jimenez, Carlos and Gouas, Doriane and Osorio, German and Hoyos, Sergio and Restrepo, Juan Carlos and Correa, Gonzalo and Jaramillo, Sergio and Lopez, Rocio and Bravo, Luis Eduardo and Arbelaez, Maria Patricia and Scoazec, Jean-Yves and Abedi-Ardekani, Behnoush and Santella, Regina M and Chemin, Isabelle and Hainaut, Pierre},
title = {Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia},
journal = {Hepatitis Research and Treatment},
year = {2011},
doi = {10.1155/2011/582945}
}
EUVIMED